The Union Health Secretary and the ICMR DG submitted a briefing to their members on the development and distribution of the coronavirus vaccine with parliamentary health panel and responded to their queries
The Health Secretary and the Director General (DG) of the Indian Council of Medical Research (ICMR) briefed the panel on “Vaccine Development, Distribution Management and Mitigation of Pandemic Covid-19” in accordance with the agenda of the meeting of the Parliamentary Standing Committee on Health and Family Welfare.
Prime Minister Narendra Modi has called the world’s largest inoculation programme, the panel meeting will be held days before the start of the countrywide Covid-19 vaccination drive on 16 January.
Priority will be given to the country’s nearly three crore healthcare and frontline workers in this drive.
Two Covid-19 vaccines, Oxford’s Covishield, manufactured in the country by the Serum Institute of India (SII), and Bharat Biotech’s Covaxin, have recently been approved by India for restricted emergency use.
According to the Covid-19 Vaccine Operational Guidelines, the shots will first be offered to an estimated one crore healthcare worker and around two crore frontline workers, and then to individuals over 50 years of age, followed by those under 50 years of age with associated comorbidities, based on the evolving pandemic situation.